Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment.
Saved in:
| Title: | Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. |
|---|---|
| Authors: | Stefan N; Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany; Institute of Diabetes Research and Metabolic Diseases, Helmholtz Centre Munich, Tübingen, Germany; German Center for Diabetes Research, Neuherberg, Germany. Electronic address: norbert.stefan@med.uni-tuebingen.de., Yki-Järvinen H; Department of Medicine, University of Helsinki, Helsinki, Finland; Minerva Foundation Institute for Medical Research, Helsinki, Finland., Neuschwander-Tetri BA; Division of Gastroenterology and Hepatology, Saint Louis University, St. Louis, MO, USA. |
| Source: | The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2025 Feb; Vol. 13 (2), pp. 134-148. Date of Electronic Publication: 2024 Dec 13. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
